Usual interstitial pneumonia preceding collagen vascular disease: a retrospective case control study of patients initially diagnosed with idiopathic pulmonary fibrosis
- PMID: 24736601
- PMCID: PMC3988132
- DOI: 10.1371/journal.pone.0094775
Usual interstitial pneumonia preceding collagen vascular disease: a retrospective case control study of patients initially diagnosed with idiopathic pulmonary fibrosis
Abstract
Background: The aim of this study was to evaluate the cumulative incidence and the predictive factors for collagen vascular disease (CVD) in patients initially diagnosed with idiopathic pulmonary fibrosis (IPF), and to examine the features of patients who then developed CVD.
Methods: This was a retrospective review of 111 consecutive patients with IPF diagnosed at our institution. None of the patients fulfilled any of the CVD criteria from the American College of Rheumatology (ACR) within 6 months or more after the diagnosis of IPF.
Results: Ten patients (9.0%) developed CVD during the follow-up period: four had rheumatoid arthritis (RA); four had microscopic polyangiitis (MPA); one had systemic sclerosis (SSc); and one had SSc and Sjogren's syndrome (SjS). The mean time until CVD diagnosis was 3.9 years. The cumulative incidences of CVD at 1, 5, and 10 years were 0.91%, 9.85%, and 15.5%, respectively. Patients who developed CVD were significantly younger, more likely to be women and had a better prognosis than those with IPF. Cox proportional hazards regression analysis showed that female sex and the presence of lymphoid aggregates with germinal centers were significantly associated with the occurrence of CVD in patients initially diagnosed with IPF.
Conclusions: CVD is an important underlying condition in IPF, and shows better prognosis. The possibility of the development of CVD should remain a consideration in the follow-up of IPF.
Conflict of interest statement
Figures




Similar articles
-
Nonspecific interstitial pneumonia preceding diagnosis of collagen vascular disease.Respir Med. 2016 Aug;117:40-7. doi: 10.1016/j.rmed.2016.05.030. Epub 2016 Jun 1. Respir Med. 2016. PMID: 27492512
-
Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia.Chest. 2009 Jul;136(1):23-30. doi: 10.1378/chest.08-2572. Epub 2009 Mar 2. Chest. 2009. PMID: 19255290
-
Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic.Respiration. 2012;83(1):20-7. doi: 10.1159/000329893. Epub 2011 Sep 6. Respiration. 2012. PMID: 21912082
-
Systematic review and meta-analysis of clinical significance of autoantibodies for idiopathic pulmonary fibrosis.BMJ Open. 2019 May 29;9(5):e027849. doi: 10.1136/bmjopen-2018-027849. BMJ Open. 2019. PMID: 31147365 Free PMC article.
-
Idiopathic pulmonary fibrosis-an epidemiological and pathological review.Clin Rev Allergy Immunol. 2011 Apr;40(2):117-34. doi: 10.1007/s12016-010-8211-5. Clin Rev Allergy Immunol. 2011. PMID: 20838937 Review.
Cited by
-
Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review.Eur Respir Rev. 2021 Nov 8;30(162):210123. doi: 10.1183/16000617.0123-2021. Print 2021 Dec 31. Eur Respir Rev. 2021. PMID: 34750115 Free PMC article. Review.
-
Clinical Implication of Proteinase-3-antineutrophil Cytoplasmic Antibody in Patients with Idiopathic Interstitial Pneumonias.Lung. 2016 Apr;194(2):235-42. doi: 10.1007/s00408-016-9851-x. Epub 2016 Feb 12. Lung. 2016. PMID: 26873743
-
Decision-Making Strategy for the Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD).J Clin Med. 2021 Aug 25;10(17):3806. doi: 10.3390/jcm10173806. J Clin Med. 2021. PMID: 34501253 Free PMC article. Review.
-
Interstital lung disease in ANCA vasculitis.Autoimmun Rev. 2017 Jul;16(7):722-729. doi: 10.1016/j.autrev.2017.05.008. Epub 2017 May 4. Autoimmun Rev. 2017. PMID: 28479484 Free PMC article. Review.
-
The Diagnosis and Treatment of Pulmonary Fibrosis.Dtsch Arztebl Int. 2021 Mar 5;118(Forthcoming):152-62. doi: 10.3238/arztebl.m2021.0018. Online ahead of print. Dtsch Arztebl Int. 2021. PMID: 33531115 Free PMC article.
References
-
- Douglas WW, Tazelaar HD, Hartman TE, Hartman RP, Decker PA, et al. (2001) Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 164: 1182–1185. - PubMed
-
- Bouros D, Wells AU, Nicholson AG, Colby TV, Polychronopoulos V, et al. (2002) Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 165: 1581–1586. - PubMed
-
- Ito I, Nagai S, Kitaichi M, Nicholson AG, Johkoh T, et al. (2005) Pulmonary manifestations of primary Sjogren’s syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 171: 632–638. - PubMed
-
- Lee HK, Kim DS, Yoo B, Seo JB, Rho JY, et al. (2005) Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 127: 2019–2027. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical